期刊： CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021; 15 ()
Background: Identifying the genes and signaling pathways related to chemoresistance might facilitate the development of novel therapeutic strategies f......
期刊： CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021; 15 ()
Lymphoid neoplasms encompass a heterogeneous group of malignancies with a predilection for immunocompromised individuals, and the disease burden of ly......
期刊： CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021; 15 ()
Here, we reported the rare case of primary pleural squamous cell carcinoma (PPSCC) in a 71-year-old male patient. After chemo and targeted therapies, ......
期刊： CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021; 15 ()
Background: The prognosis of patients with pancreatic ductal adenocarcinoma (PDAC) of pancreatic head remains poor, even after potentially curative R0......
期刊： CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021; 15 ()
Background: Glioma is the central nervous system tumor with the highest incidence rate and the molecular detection of gliomas has been the focus of re......
期刊： CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021; 15 ()
Pathogenic germline mutations occurring in the BRCA1 (MIM:113705) and BRCA2 (MIM: 600185), which always result in truncated protein or nonsense-mediat......
期刊： CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021; 15 ()
Poly (ADP-ribose) polymerase (PARP) inhibitors have demonstrated great promise for treating cancers with homologous recombination (HR) defects, such a......
期刊： CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021; 15 ()
OBJECTIVE: Over 1 million new cases of hepatocellular carcinoma (HCC) are diagnosed worldwide every year. Its prognosis remains poor. and the 5-year s......
期刊： CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2020; 14 ()
Immunotherapy, as a novel treatment, has brought new hope to many patients with cancer, including patients with lung cancer. However, the overall cure......
期刊： CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2020; 14 ()
PURPOSE: About one-third of nonsmall cell lung cancer (NSCLC) patients develop brain metastases (BM). However, there is an unmet need for early diagno......
期刊： CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2020; 14 ()
Motivation: Although several prognostic signatures for lung adenocarcinoma (LUAD) have been developed, they are mainly based on a single-omics data se......
期刊： CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2020; 14 ()
Background: To develop a novel nomogram to improve the preoperative diagnosis of pathological grade of upper tract urothelial carcinoma (UTUC). Method......
期刊： CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022; 16 ()
BACKGROUND: EGFR tyrosine kinase inhibitor (TKI) is recommended as the first-line therapy for patients with EGFR-mutant metastatic non-small cell lung......
期刊： CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022; 16 ()
Nasopharyngeal carcinoma (NPC) is one of the most common head and neck malignancies, and the primary treatment methods are radiotherapy and chemothera......
期刊： CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022; 16 ()
BACKGROUND: The influence of the number of removed lymph nodes (RLNs) on patients with early-stage cervical cancer (ESCC) is still questionable. The o......
